These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19692100)

  • 1. Parallel evolutions of the growth rate of newly diagnosed HIV cases and the proportion of potentially infective patients in Cayenne French Guiana: should HAART be used to curb the epidemic?
    Nacher M; Vantilcke V; Huber F; El Guedj M; Vaz T; Magnien C; Djossou F; Mahamat A; Dabis F; Couppié P
    Public Health; 2009 Aug; 123(8):573-4. PubMed ID: 19692100
    [No Abstract]   [Full Text] [Related]  

  • 2. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.
    Lima VD; Johnston K; Hogg RS; Levy AR; Harrigan PR; Anema A; Montaner JS
    J Infect Dis; 2008 Jul; 198(1):59-67. PubMed ID: 18498241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for follow-up interruption of HIV patients in French Guiana.
    Nacher M; El Guedj M; Vaz T; Nasser V; Randrianjohany A; Alvarez F; Sobesky M; Magnien C; Couppié P
    Am J Trop Med Hyg; 2006 May; 74(5):915-7. PubMed ID: 16687702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Highly active antiretroviral therapy].
    Jablonowski H
    MMW Fortschr Med; 2009 Apr; 151(18):58-61. PubMed ID: 19769079
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-HIV agents. Should HAART begin right after an HIV diagnosis?
    TreatmentUpdate; 2009; 21(3):2-3. PubMed ID: 19630120
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased incidence of leprosy following HAART initiation: a manifestation of the immune reconstitution disease.
    Couppié P; Domergue V; Clyti E; El Guedj M; Vaz T; Sainte-Marie D; Marty C; Nacher M
    AIDS; 2009 Jul; 23(12):1599-600. PubMed ID: 19487911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased incidence of mucosal candidiasis after HAART initiation: a benign form of immune reconstitution disease?
    Nacher M; Vantilcke V; Huber F; Mahamat A; El Guedj M; Randrianjohany A; Clyti E; Aznar C; Carme B; Couppié P
    AIDS; 2007 Nov; 21(18):2534-6. PubMed ID: 18025892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
    Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
    Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.
    Kolte L; Ryder LP; Albrecht-Beste E; Jensen FK; Nielsen SD
    Scand J Immunol; 2009 Dec; 70(6):608-13. PubMed ID: 19906203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrition. Study finds vitamin B12 levels low in some HAART users.
    TreatmentUpdate; 2003 Oct; 15(6):6-7. PubMed ID: 17216864
    [No Abstract]   [Full Text] [Related]  

  • 11. Trends in the European HIV/AIDS epidemic: a perspective from Italy.
    Madeddu G; Rezza G; Mura MS
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):25-36. PubMed ID: 19622055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications & side effects. HAART and bones-mixed messages.
    TreatmentUpdate; 2007; 19(4):3-5. PubMed ID: 17969257
    [No Abstract]   [Full Text] [Related]  

  • 13. Brazilian HIV-infected population: assessment of the needs of endodontic treatment in the post-highly active antiretroviral therapy era.
    de Brito LC; da Rosa MA; Lopes VS; e Ferreira EF; Vieira LQ; Sobrinho AP
    J Endod; 2009 Sep; 35(9):1178-81. PubMed ID: 19720212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Highly active antiretroviral therapy. Building on experience in developing new strategies].
    Paukstadt W
    MMW Fortschr Med; 2011 May; 153(18):39. PubMed ID: 21604595
    [No Abstract]   [Full Text] [Related]  

  • 16. Country of infection among HIV-infected patients born abroad living in French Guiana.
    Nacher M; Adriouch L; Van Melle A; Parriault MC; Adenis A; Couppié P
    PLoS One; 2018; 13(2):e0192564. PubMed ID: 29420591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Also consider cardiovascular risk. Every HIV patient "his" HAART].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():58-60. PubMed ID: 19031565
    [No Abstract]   [Full Text] [Related]  

  • 18. Temporal trend of the proportion of patients presenting with advanced HIV in French Guiana: stuck on the asymptote?
    Nacher M; Huber F; Adriouch L; Djossou F; Adenis A; Couppié P
    BMC Res Notes; 2018 Nov; 11(1):831. PubMed ID: 30477588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic and diagnostic advances in the HAART era.
    Cheng B
    Res Initiat Treat Action; 2005; 11(1):42-5. PubMed ID: 16208819
    [No Abstract]   [Full Text] [Related]  

  • 20. AIDS-related Histoplasma capsulatum var. capsulatum infection: 25 years experience of French Guiana.
    Huber F; Nacher M; Aznar C; Pierre-Demar M; El Guedj M; Vaz T; Vantilcke V; Mahamat A; Magnien C; Chauvet E; Carme B; Couppié P
    AIDS; 2008 May; 22(9):1047-53. PubMed ID: 18520348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.